Thursday, August 4, 2016

U.S. SEC charges cardiologist with insider trading on drug trials

WASHINGTON, Aug 4 (Reuters) - The U.S. Securities and

Exchange Commission on Thursday charged a cardiologist with

insider trading on confidential developments as he worked on a

clinical drug trial.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)